This Breakthrough Cancer Drug Might Be the Closest We’ve Come to a Cure
ASCO Data Shows New Therapy Keeps Myeloma Patients in Remission for 5+ Years Multiple myeloma, a complex blood cancer that affects plasma cells, has long posed a formidable challenge in oncology. Over the decades, treatment options have evolved from conventional chemotherapy to proteasome inhibitors, immunomodulatory drugs, and monoclonal antibodies. Despite these advances, long-term survival has […]
This Breakthrough Cancer Drug Might Be the Closest We’ve Come to a Cure Read More »